Metabolic syndrome, cognitive performance, and dementia

Journal of Alzheimer's Disease

Volumn 30, Issue SUPPL.2, 2012, Pages

  Crichton, Georgina E ^a   Elias, Merrill F ^b   Buckley, Jonathan D ^a   Murphy, Karen J ^a   Bryan, Janet ^a   Frisardi, Vincenza ^c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b University of Maine   (United States)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Alzheimer's disease; cognition; dementia; metabolic syndrome

Indexed keywords

INSULIN;

AGING; ALZHEIMER DISEASE; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84862986464     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111022     Document Type: Review

References (56)

1. United Nations, World Population Ageing 2009. http://www. un.org/esa/population/publications/WPA2009/WPA2009 WorkingPaper.pdf, Accessed August 10, 2010.
2. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB (2000) The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 57, 808-813. (Pubitemid 30397182)
3. Tierney MC, Moineddin R, McDowell I (2010) Prediction of all-cause dementia using neuropsychological tests within 10 and 5 years of diagnosis in a community-based sample. J Alzheimers Dis 22, 1231-1240.
4. Tierney MC, Yao C, Kiss A, McDowell I (2005) Neuropsy-chological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64, 1853-1859. (Pubitemid 40800697)
5. Waldstein SR, Elias MF, eds. (2001) Neuropsychology of Cardiovascular Disease. Lawrence Erlbaum Associates, New Jersey.
6. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62, 1556-1560. (Pubitemid 41434560)
7. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545-551. (Pubitemid 41170713)
8. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277-281.
9. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB (2003) Lower cognitive function in the presence of obesity and hypertension: The Framingham heart study. Int J Obesity 27, 260-268. (Pubitemid 36255810)
10. Arnolov J, Ingelsson E, Sundstrom J, Lind L (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121, 230-U288.
11. Ho JS, Cannaday JJ, Barlow CE, Mitchell TL, Cooper KH, FitzGeraldSJ (2008) Relationofthe numberofmetabolic syndrome risk factors with all-cause and cardiovascular mortality. Am J Cardiol 102, 689-692.
12. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the Study of Obesity.Circulation 120, 1640-1645.
13. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH (2006) Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 37, 1060-1064.
14. Arsenault BJ, DespresJP, Stroes ESG, Wareham NJ, Kastelein JJP, Khaw KT, Boekholdt SM (2010) Lipid assessment, metabolic syndrome and coronary heart disease risk. Eur J Clin Invest 40, 1081-1093.
15. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23, 469-480.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13, 322-327. (Pubitemid 41579599)
17. Hao ZL, Wu B, Wang DR, Liu M (2011) Association between metabolic syndrome and cognitive decline: A systematic review of prospective population-based studies. Acta Neu-ropsychiatrica 23, 69-74.
18. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F (2011) Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 32, 1932-1941.
19. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F, Italian Longitudinal Study A (2010) Metabolic syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry 81, 433-440.
20. Lezak MD, Howieson DB, Loring DW (2004) Neuropsycho-logical Assessment, Oxford University press, New York.
21. Segura B, Jurado MA, Freixenet N, Albuin C, Muniesa J, Junque C (2009) Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 462, 49-53.
22. van den Berg E, Dekker JM, Nijpels G, Kessels RPC, Kappelle LJ, de Haan EHF, Heine RJ, Stehouwer CDA, Biessels GJ (2008) Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn Study. Dement Geriatr Cogn Disord 26, 261-269.
23. Isik AT, Cankurtaran M, Bozoglu E, Comert B, Doruk H, Mas MR (2007) Is there any relation between insulin resistance and cognitive function in the elderly? Int Psychogeriatr 19, 745-756. (Pubitemid 47037102)
24. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia, the Three-City Study. Diabetes Care 32, 169-174.
25. Razay G, Vreugdenhil A, Wilcock G (2007) The metabolic syndrome and Alzheimer disease. Arch Neurol 64, 93-96. (Pubitemid 46072429)
26. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi A, Laakso M, Kuusisto J (2006) Association of metabolic syndrome with Alzheimer disease: A population-based study. Neurology 67, 843-847. (Pubitemid 44394200)
27. Yaffe K, Weston AL, Blackwell T, Krueger KA (2009) The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 66, 324-328.
28. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW (2007) Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30, 2655-2660. (Pubitemid 47547816)
29. van den Berg E, Biessels GJ, de Craen AJM, Gussekloo J, Westendorp RGJ (2007) The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69, 979-985. (Pubitemid 47366051)
30. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192. (Pubitemid 47312668)
31. Cavalier M, Ropele S, Petrovic K, Pluta-Fuerst A, Homayoon N, Enzinger C, Grazer A, Katschnig P, Schwingenschuh P, Berghold A, Schmidt R (2010) Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care 33, 2489-2495.
32. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R (2007) Metabolic syndrome and cognitive function:A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 23, 29-34. (Pubitemid 46005788)
33. Knopman DS, Mosley TH, Catellier DJ, Coker LH (2009) Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study. Alzheimers Dement 5, 207-214.
34. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N (2007) Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55, 758-762. (Pubitemid 46668964)
35. Forti P, Pisacane N, Rietti E, Lucicesare A, Olivelli V, Mar-iani E, Mecocci P, Ravaglia G (2010) Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 58, 487-492.
36. Choi SJ, Jung SS, You YS, Shin BS, Kim JE, Yoon SW, Jeon DW, Baek JH, Park SW, Lee JG, Kim YH (2008) Prevalence of Alzheimer's dementia and its risk factors in community-dwelling elderly Koreans. Psychiatry Invest 5, 78-85.
37. Rabbitt PMA ed. (1997) Methodology of Frontal and Executive Function, Psychology Press, East Sussex.
38. Gatto NM, Henderson VW, John JAS, McCleary C, Hodis HN, Mack WJ (2008) Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Aging Neuropsychol Cogn 15, 627-641.
39. Burgess GC, Braver TS, Gray JR (2006) Exactly how are fluid intelligence, working memory, and executive function related? Cognitive neuroscience approaches to investigating the mechanisms of fluid cognition. Behav Brain Sci 29, 128-129.
40. Garlick D, Sejnowski TJ (2006) There is more to fluid intelligence than working memory capacity and executive function. Behav Brain Sci 29, 134-135.
41. HeitzRP, Redick TS, Hambrick DZ, Kane MJ, Conway ARA, Engle RW (2006) Working memory, executive function, and general fluid intelligence are not the same. Behav Brain Sci 29, 135-136.
42. Roca M, Parr A, Thompson R, Woolgar A, Torralva T, Antoun N, Manes F, Duncan J (2010) Executive function and fluid intelligence after frontal lobe lesions. Brain 133, 234-247.
43. Lyon GR, Krasnegor NA (1996) Attention, Memory and Executive Function, H Paul, Brookes, Baltimore.
44. Roberts AC, Robbins TW, Weiskrantz L eds. (1998) The Pre-frontal Cortex: Executive and cognitive functions, Oxford University Press, New York.
45. Elias MF, Elias PK (1993) Hypertension affects neurobe-havioral functioning: So what's new? Psychosom Med 55, 51-54.
46. Blumenthal JA, Madden DJ, Pierce TW, Siegel WC, Appelbaum M (1993) Hypertension affects neurobehavioral functioning. Psychosom Med 55, 44-50.
47. Loehlin JC (2004) Latent variable models: An introduction to factor, path, and structural analysis, Lawrence Erlbaum Associates, Mahwah, NJ.
48. Elias PK, Elias MF, D'Agostino RB, Sullivan LM, Wolf PA (2005) Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med 67, 24-30.
49. Muldoon MF, Ryan CM, Sereika SM, Flory JD, Manuck SB (2004) Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 117, 823-829. (Pubitemid 39602790)
50. Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610, 271-280. (Pubitemid 36324470)
51. Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA (2004) Framingham stroke risk profile and lowered cognitive performance. Stroke 35, 404-409. (Pubitemid 38174420)
52. Harris RJ (2001) A primer of multivariate statistics, Lawrence Erlbaum Associates, Mahwah, NJ.
53. Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santam-ato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F (2010) Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease.Ageing Res Rev 9, 399-417.
54. Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Isinsulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21, 57-63.
55. Marra C, Ferraccioli M, Vita MG, Quaranta D, Gainotti G (2011) Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI. Curr Alzheimer Res 8, 24-31.
56. Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MTR, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A (2004) MCI conversion todementia and the APOE genotype -A prediction study with FDG-PET.Neurology 63, 2332-2234.